Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report

Canadian Association of Medical Oncology (CAMO) Survey Report

  • S. Gill BC Cancer, University of British Columbia
  • D. Hao Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary
  • H. Hirte
  • A. Campbell Canadian Association of Medical Oncologists
  • B. Colwell Dalhousie University

Abstract

 

Background  The covid-19 pandemic has presented unprecedented professional and personal challenges for the oncology community. Under the auspices of the Canadian Association of Medical Oncologists, we conducted an online national survey to better understand the impact of the pandemic on the medical oncology community in Canada.

Methods  An English-language multiple-choice survey, including questions about demographics, covid-19 risk, use of personal protective equipment (ppe), personal challenges, and chemotherapy management was distributed to Canadian medical oncologists. The survey was open from 30 March to 4 April 2020, and attracted 159 responses.

Results  More than 70% of medical oncologists expressed moderate-to-extreme concern about personally contracting covid-19 and about family members or patients (or both) contracting covid-19 from them. Despite that high level of concern, considerable variability in the use of ppe in direct cancer care was reported at the time of this survey, with 33% of respondents indicating no routine ppe use at their institutions and 69% indicating uncertainty about access to adequate ppe. Of the respondents, 54% were experiencing feelings of nervousness or anxiety on most days, and 52% were having feelings of depression or hopelessness on at least some days. Concern about aging parents or family and individual wellness represented the top personal challenges identified. The management of cancer patients has been affected, with adoption of telemedicine reported by 82% of respondents, and cessation of clinical trial accrual reported by 54%. The 3 factors deemed most important for treatment decision-making were

  • cancer prognosis and anticipated benefit from treatment,
  • risk of treatment toxicity during scarce health care access, and
  • patient risk of contracting covid-19.

Conclusions This report describes the results of the first national survey assessing the impact of the covid-19 on Canadian medical oncologists and how they deliver systemic anticancer therapies. We hope that these data will provide a framework to address the challenges identified.


Published
2020-04-14
How to Cite
Gill, S., Hao, D., Hirte, H., Campbell, A., & Colwell, B. (2020). Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report: Canadian Association of Medical Oncology (CAMO) Survey Report. Current Oncology, 27(2). https://doi.org/10.3747/co.27.6643
Section
Medical Oncology